Quick Take:

  • Silo Wellness Inc. announces that they will be listing their company on the German Börse Frankfurt exchange to expand shareholder opportunity overseas.

Silo Wellness Inc. (SILO) a wellness company in the psychedelics and functional mushroom marketplaces is pleased to announce that trading of its common shares has expanded to include overseas listing on the German Börse Frankfurt (FRA) exchange platform.

The commons shares of Silo Wellness securities began trading on Friday, April 9, 2021 on the FRA under ticker symbol 3K70 and registered under WKN: A2QQTP and/or ISIN: CA8271241082.

“Expanding our shareholder base more broadly into the European market by commencing trading on the Frankfurt exchange is an important milestone for Silo Wellness as we continue to broaden our international presence… By listing on the FRA, a wider audience of investors will now be able to actively participate in the growth of Silo Wellness as we continue to deliver on our mission as well as grow on a global basis.”

Douglas K. Gordon, Chief Executive Officer of Silo Wellness.

About Silo Wellness

The mission of Silo Wellness is to improve health and wellness by developing and introducing psychedelic medicine to reduce trauma and increase performance by destigmatizing the active compounds in psychedelics and innovating ease of administration and ingestion. Silo Wellness intends to introduce new, safe and affordable alternatives to current medicines by facilitating entry into new and emerging markets where psychedelics are legal by conducting ketamine and psilocybin wellness retreats and elsewhere by manufacturing and distributing functional mushrooms.

Since its inception, Silo Wellness’ activities have focused on: (1) development of psilocybin-free functional mushroom tinctures; (2) the development of the formulation of a psilocybin nasal spray in Jamaica; and (3) offering of Jamaican and Oregon psychedelic wellness retreats as well as the cultivation of psychedelic mushrooms in Jamaica. None of Silo Wellness’ products claim to cure or mitigate any physical or mental disease, symptoms, disorders or abnormalities.